11/07/2023 - PHARMANUTRA S.P.A.: CETILAR® IS RECONFIRMED AS MAIN SPONSOR OF THE PISA SPORTING CLUB FOR 2023-2024

PHARMANUTRA S.P.A.: CETILAR® IS RECONFIRMED AS MAIN SPONSOR OF THE

PISA SPORTING CLUB FOR 2023-2024

The partnership with the club owned by Giuseppe Corrado has been renewed. The Cetilar brand will once again be seen on the Nerazzurri's shirts as Main Sponsor for the upcoming Serie B football championship season. Yesterday the official presentation took place at the Logge dei Banchi in Pisa.

Pisa, 11 July 2023 - PharmaNutra S.p.A.(MTA; Ticker PHN), a company specialising in the sector of mineral-based nutritional supplements and medical devices for muscles and joints, announced that it has renewed its partnership for next season with Pisa Sporting Club, the club owned by Giuseppe Corrado, which will play in next year's Serie B football championship.

The now well-established partnership between two of the most important and well-known organisations in the area will continue. Once again, the Cetilar® brand will have its pride and joy shown on the official match kits of the Pisa Sporting Club, which appeared for the first time in the final part of the 2019-2020 season.

Cetilar® will therefore be the Main Sponsor also for the 2023-2024 season, which will see the Pisa Sporting Club at the starting line of the Cadetto championship, embellishing the Adidas-branded Match Kits that were presented yesterday afternoon in the evocative setting of Logge di Banchi, in Pisa.

"Pisa Calcio is an outstanding football club and represents a fundamental core value for the city: we are therefore very pleased to continue to be at its side for the next competitive season, with our Cetilar® brand prominently displayed on the black and blue shirts. The goal is to pursue the journey that began three years ago, working together in pursuit of continuous improvement, which we all hope will bring great satisfaction to the team and its passionate fans," explains Carlo Volpi, CEO of PharmaNutra S.p.A. The CEO does not fail to emphasise how 2023 is a real milestone in the company's history, including the 20th anniversary of its foundation, the opening of the American subsidiary PharmaNutra USA, the upcoming inauguration of the new headquarters in San Rossore and the launch of Cetilar® Nutrition, the new line of products dedicated to sports nutrition.

"The launch of the new shirts is always an enjoyable tradition", commented Giuseppe Corrado, President of the Pisa Sporting Club, "just like our partnership, but above all our mutual respect, with PharmaNutra has become the starting point of every competitive season. Continuing on the same journey together is a natural step for two businesses that best represent the excellence of our territory. It is a source of pride for us to carry the Cetilar® brand on our shirts, just as I am convinced that it is a prestigious opportunity for PharmaNutra to link its brand to our glorious club".

Created as a line of products dedicated to the well-being of muscles and joints based on Cetylated Esters (CFA), an exclusive PharmaNutra patent is available in Cream, Patch, Tape and Gold versions. Furthermore,

since last March, Cetilar® also launched Nutrition, a new line of products dedicated to nutrition and improving the performance of competitive athletes. It's the result of years of studies in the nutritional field that the company, founded in 2003 by brothers Andrea and Roberto Lacorte, has carried on thanks to its technologies and its patents.

PharmaNutra S.p.A.

Founded and led by Chairman Andrea Lacorte and Vice Chairman Roberto Lacorte, PharmaNutra is a company established in 2003 that develops unique nutritional supplements and innovative medical devices, taking care of the entire production process, from proprietary raw materials to the finished product. PharmaNutra is a leader in the production of iron-based nutritional supplements under the SiderAL®brand, where it holds important patents on Sucrosomal®Technology, and is considered one of the emerging top players in the medical device sector dedicated to restoring joint capacity thanks to the Cetilar®brand. The effectiveness of the products is demonstrated by a number of scientific evidences, including more than 120 publications. In Italy, the sales activity is carried out through a network of over 160 Commercial Scientific Informants serving the medical class and dedicated to the exclusive marketing of products to pharmacies and parapharmacies throughout the national territory. Sales abroad are guaranteed in over 71 countries through 45 partners selected among the leading pharmaceutical companies. Over the years, the Group has developed a precise strategy in the management and production of intellectual property, based on the integrated management of all components: proprietary raw materials, patents, trademarks and clinical evidence.

PharmaNutra.it

For further details:
PharmaNutra S.p.A.	Press Office - Spriano Communication & Partners
Via Delle Lenze, 216/b - 56122 Pisa, Italy	Via Santa Radegonda, 16 - 20121 Milan, Italy
Tel. [phone]	Tel. [phone]
[e-mail]
Internal Press Office	Matteo Russo
[e-mail]	[e-mail]
	Cristina Tronconi
	[e-mail]